Teva receives FDA approval for monthly schizophrenia injection Weltruza
Teva said the US Food and Drug Administration approved Weltruza, a once-monthly injection for adults with schizophrenia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.